Carvedilol RFP   2

Background
All Ordering Activities under the VA and all Ordering Activities under the Department of Defense (DoD) acquire their pharmaceutical requirements through their respective Pharmaceutical Prime Vendor (PPV) Programs, hereafter referred to as the VA PPV Program and DoD PPV Program or jointly as PPV Programs. The PPV Programs are separate contracts which establish the fees for the distribution of pharmaceutical products that are distributed through the PPV Programs on Federal Government contracts. A contract resulting from this solicitation establishes the VA National Contract prices for the products listed in the schedule of supplies that will be distributed through the PPV Programs. The contractor shall follow all appropriate requirements as implemented in Drug Supply Chain Security Act (DSCSA).

Work Details
The solicitation is for Carvedilol Tablets. One award will be made in the aggregate for line items 1, 2, 3, 4, 5, 6, 7 and 8. Offerors must submit a price for the base year and all four one-year options for all line items. Prices offered shall not exceed two decimal places. Offered prices must include an 11 digit NDC number for each offered drug that is unique to the Offeror's company. The solicitation also includes details on Contract Effective Date, Implementation Period, and Ordering Period.

Period of Performance
Contract Effective Date: To be determined at the time of contract award; Implementation Period: Maximum of a 60-day Implementation period if awarded after 02/29/2023; Ordering Period: Base year Ordering Period will be in effect for one year.

Place of Performance
The products specified in the schedule are to be provided at various facilities/agencies including all Department of Veterans Affairs (VA) facilities, all Department of Defense (DoD) Pharmaceutical Prime Vendor Program facilities, Indian Health Service (IHS) facilities, Bureau of Prisons (BOP) facilities, Captain James A. Lovell Federal Health Care Center (FHCC), and all Option 2 State Veteran Homes.